Brunet JS - Search Results

1

Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.

Narod SA, Dubé MP, Klijn J, Lubinski J, Lynch HT, Ghadirian P, Provencher D, Heimdal K, Moller P, Robson M, Offit K, Isaacs C, Weber B, Friedman E, Gershoni-Baruch R, Rennert G, Pasini B, Wagner T, Daly M, Garber JE, Neuhausen SL, Ainsworth P, Olsson H, Evans G, Osborne M, Couch F, Foulkes WD, Warner E, Kim-Sing C, Olopade O, Tung N, Saal HM, Weitzel J, Merajver S, Gauthier-Villars M, Jernstrom H, Sun P, Brunet JS. Narod SA, et al. Among authors: brunet js. J Natl Cancer Inst. 2002 Dec 4;94(23):1773-9. doi: 10.1093/jnci/94.23.1773. J Natl Cancer Inst. 2002. PMID: 12464649

2

Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1-related breast carcinoma.

Foulkes WD, Metcalfe K, Hanna W, Lynch HT, Ghadirian P, Tung N, Olopade O, Weber B, McLennan J, Olivotto IA, Sun P, Chappuis PO, Bégin LR, Brunet JS, Narod SA. Foulkes WD, et al. Among authors: brunet js. Cancer. 2003 Oct 15;98(8):1569-77. doi: 10.1002/cncr.11688. Cancer. 2003. PMID: 14534871 Free article.

3

Risk of pancreatic cancer among individuals with a family history of cancer of the pancreas.

Ghadirian P, Liu G, Gallinger S, Schmocker B, Paradis AJ, Lal G, Brunet JS, Foulkes WD, Narod SA. Ghadirian P, et al. Among authors: brunet js. Int J Cancer. 2002 Feb 20;97(6):807-10. doi: 10.1002/ijc.10123. Int J Cancer. 2002. PMID: 11857359 Free article.

4

Tamoxifen may be an effective adjuvant treatment for BRCA1-related breast cancer irrespective of estrogen receptor status.

Foulkes WD, Goffin J, Brunet JS, Bégin LR, Wong N, Chappuis PO. Foulkes WD, et al. Among authors: brunet js. J Natl Cancer Inst. 2002 Oct 2;94(19):1504-6. doi: 10.1093/jnci/94.19.1504-a. J Natl Cancer Inst. 2002. PMID: 12359859 No abstract available.

5

Impact of germline BRCA1 mutations and overexpression of p53 on prognosis and response to treatment following breast carcinoma: 10-year follow up data.

Goffin JR, Chappuis PO, Bégin LR, Wong N, Brunet JS, Hamel N, Paradis AJ, Boyd J, Foulkes WD. Goffin JR, et al. Among authors: brunet js. Cancer. 2003 Feb 1;97(3):527-36. doi: 10.1002/cncr.11080. Cancer. 2003. PMID: 12548593 Free article.

6

Long-term outcome after neo-adjuvant chemotherapy for breast cancer in BRCA1/2 carriers.

Wong Wong Keet A, Al-Rafae M, Chappuis PO, Brunet JS, Ghadirian P, Foulkes WD. Wong Wong Keet A, et al. Among authors: brunet js. Int J Cancer. 2009 Nov 1;125(9):2236-8. doi: 10.1002/ijc.24596. Int J Cancer. 2009. PMID: 19618461 Free article. No abstract available.

7

The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer.

Foulkes WD, Brunet JS, Stefansson IM, Straume O, Chappuis PO, Bégin LR, Hamel N, Goffin JR, Wong N, Trudel M, Kapusta L, Porter P, Akslen LA. Foulkes WD, et al. Among authors: brunet js. Cancer Res. 2004 Feb 1;64(3):830-5. doi: 10.1158/0008-5472.can-03-2970. Cancer Res. 2004. PMID: 14871808

8

Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancer.

Arnes JB, Brunet JS, Stefansson I, Bégin LR, Wong N, Chappuis PO, Akslen LA, Foulkes WD. Arnes JB, et al. Among authors: brunet js. Clin Cancer Res. 2005 Jun 1;11(11):4003-11. doi: 10.1158/1078-0432.CCR-04-2064. Clin Cancer Res. 2005. PMID: 15930334

9

Use of immunohistochemical markers can refine prognosis in triple negative breast cancer.

Tischkowitz M, Brunet JS, Bégin LR, Huntsman DG, Cheang MC, Akslen LA, Nielsen TO, Foulkes WD. Tischkowitz M, et al. Among authors: brunet js. BMC Cancer. 2007 Jul 24;7:134. doi: 10.1186/1471-2407-7-134. BMC Cancer. 2007. PMID: 17650314 Free PMC article.

10

Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes.

Rakha EA, Elsheikh SE, Aleskandarany MA, Habashi HO, Green AR, Powe DG, El-Sayed ME, Benhasouna A, Brunet JS, Akslen LA, Evans AJ, Blamey R, Reis-Filho JS, Foulkes WD, Ellis IO. Rakha EA, et al. Among authors: brunet js. Clin Cancer Res. 2009 Apr 1;15(7):2302-10. doi: 10.1158/1078-0432.CCR-08-2132. Epub 2009 Mar 24. Clin Cancer Res. 2009. PMID: 19318481

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

45 results

Search Page